Entacapone sodium salt

Modify Date: 2026-07-16 14:53:41

Entacapone sodium salt Structure
Entacapone sodium salt structure
Common Name Entacapone sodium salt
CAS Number 1047659-02-8 Molecular Weight 327.26800
Density N/A Boiling Point N/A
Molecular Formula C14H14N3NaO5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Entacapone sodium salt


Entacapone is a specific, potent, peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment. IC50 Value: 151 nMTarget: COMTin vitro: Entacapone inhibits catechol-O-methyltransferase(COMT) with similar IC50 in different tissues including live, duodenum, kidney and lung, but entacapone is more active than tolcapone in those tissues. Entacapone (< 100 μM) is a potent inhibitor of α-syn and β-amyloid (Aβ) oligomerization and fibrillogenesis, and also protects against extracellular toxicity induced by the aggregation of both proteins in PC12 cells.in vivo: Levodopa/carbidopa/entacapone has been shown to improve the pharmacokinetic profile of levodopa and provide superior symptomatic control compared with conventional levodopa/dopa decarboxylase inhibitor therapy. We report four case histories describing clinical experience of using levodopa/carbidopa/entacapone 200/50/200 mg, one of the latest doses of this formulation, in a range of patients with Parkinson's disease. These cases illustrate that levodopa/carbidopa/entacapone 200/50/200 mg provides improvements in symptomatic control.Clinical trial: The combination product carbidopa/levodopa/entacapone (CLE) was approved in 2003 for the treatment of PD patients.

 Names

This table lists Chinese names, IUPAC names and various aliases of this chemical substance.

Name entacapone, sodium salt
Synonym More Synonyms

 Entacapone sodium salt Biological Activity

This table contains bioactivity, target information and biological‑assay experimental data of this compound.

Description Entacapone is a specific, potent, peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment. IC50 Value: 151 nMTarget: COMTin vitro: Entacapone inhibits catechol-O-methyltransferase(COMT) with similar IC50 in different tissues including live, duodenum, kidney and lung, but entacapone is more active than tolcapone in those tissues. Entacapone (< 100 μM) is a potent inhibitor of α-syn and β-amyloid (Aβ) oligomerization and fibrillogenesis, and also protects against extracellular toxicity induced by the aggregation of both proteins in PC12 cells.in vivo: Levodopa/carbidopa/entacapone has been shown to improve the pharmacokinetic profile of levodopa and provide superior symptomatic control compared with conventional levodopa/dopa decarboxylase inhibitor therapy. We report four case histories describing clinical experience of using levodopa/carbidopa/entacapone 200/50/200 mg, one of the latest doses of this formulation, in a range of patients with Parkinson's disease. These cases illustrate that levodopa/carbidopa/entacapone 200/50/200 mg provides improvements in symptomatic control.Clinical trial: The combination product carbidopa/levodopa/entacapone (CLE) was approved in 2003 for the treatment of PD patients.
Related Catalog
References

[1]. Di Giovanni, S., et al., Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity. J Biol Chem, 2010. 285(20): p. 14941-54.

[2]. Jenner, P., Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation. Neurology, 2004. 62(1 Suppl 1): p. S47-55.

[3]. Hamaue, N., et al., Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus. Brain Res, 2010. 1309: p. 110-5.

 Chemical & Physical Properties

This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.

Molecular Formula C14H14N3NaO5
Molecular Weight 327.26800
Exact Mass 327.08300
PSA 133.21000
LogP 2.74278
InChIKey UMQUSXKIIWDDTK-OAZHBLANSA-M
SMILES CCN(CC)C(=O)C(C#N)=Cc1cc(O)c([O-])c([N+](=O)[O-])c1.[Na+]
Storage condition 2-8℃

 Synonyms

This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.

Entacapone (sodium salt)

 Entacapone sodium salt | FAQ

This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.

Q: What is the SMILES notation of entacapone, sodium salt?
A: SMILES notation of entacapone, sodium salt is CCN(CC)C(=O)C(C#N)=Cc1cc(O)c([O-])c([N+](=O)[O-])c1.[Na+].
Q: What is the LogP of entacapone, sodium salt?
A: LogP of entacapone, sodium salt is 2.74278.
Q: What is the molecular weight of entacapone, sodium salt?
A: Molecular weight of entacapone, sodium salt is 327.26800.
Q: What is the English name of entacapone, sodium salt?
A: The English name of entacapone, sodium salt is entacapone, sodium salt.
Q: What is the polar surface area (PSA) of entacapone, sodium salt?
A: Polar surface area (PSA) of entacapone, sodium salt is 133.21000.
Q: What is the InChIKey of entacapone, sodium salt?
A: InChIKey of entacapone, sodium salt is UMQUSXKIIWDDTK-OAZHBLANSA-M.
Q: What are the storage conditions for entacapone, sodium salt?
A: Storage conditions for entacapone, sodium salt: 2-8℃.
Q: What is the molecular formula of entacapone, sodium salt?
A: Molecular formula of entacapone, sodium salt is C14H14N3NaO5.
Q: What is the CAS number of entacapone, sodium salt?
A: CAS number of entacapone, sodium salt is 1047659-02-8.
Q: What English synonyms does entacapone, sodium salt have?
A: English synonyms of entacapone, sodium salt: Entacapone (sodium salt).

 Entacapone sodium saltfactory

This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.

Shanghai Nianxing Industrial Co., Ltd
Dayang Chem (Hangzhou) Co., Ltd.
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.